Education
About Us
Working with TipRanks
Follow Us
Becton Dickinson And Company (BDX)
NYSE:BDX
BDX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$163.33 - $251.99
Previous CloseN/A
Volume443.35K
Average Volume (3M)3.38M
Market Cap
$48.91B
Enterprise Value$66.53B
Total Cash (Recent Filing)$683.00M
Total Debt (Recent Filing)$19.27B
Price to Earnings (P/E)32.6
Beta0.36
Next Earnings
Aug 07, 2025EPS Estimate
3.43Next Dividend Ex-Date
Jun 09, 2025Dividend Yield2.33%
Share Statistics
EPS (TTM)3.35
Shares Outstanding286,607,420
10 Day Avg. Volume2,169,218
30 Day Avg. Volume3,383,237
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)1.91
Price to Sales (P/S)0.00
P/FCF Ratio18.50
Enterprise Value/Market Cap1.36
Enterprise Value/Revenue0.82
Enterprise Value/Gross Profit7.16
Enterprise Value/Ebitda4.06
Forecast
1Y Price Target
$200.73Price Target Upside17.37% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Becton Dickinson News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAdjusted EPS of $3.35 exceeded the $3.28 target, representing 5.7% growth on a reported basis and 7.3% growth on a constant currency basis.
ProfitabilityBDX has momentum and a long runway ahead with BD Excellence, which is expected to drive gross margin improvements.
Revenue GrowthPharm systems are seeing positive order movement and the advanced patient monitoring acquisition is expected to contribute to revenue in the second half.
Bears Say
Earnings ExpectationsBecton, Dickinson and Co. reported lower-than-expected revenue for the fiscal second quarter, indicating a challenging operating environment.
Management And StrategyExecution still hasn’t improved and thus analysts can no longer defend BDX as a stock that’s too cheap and no longer defend BDX as a defensive stock.
Market ConditionsMacro factors are impacting BDX growth rate including declines in China due to VBP and reduced biosciences growth from funding constraints.
Ownership Overview
0.13% Insiders
25.10% Mutual Funds
26.63% Other Institutional Investors
26.23% Public Companies and Individual Investors
BDX FAQ
What was Becton Dickinson And Company’s price range in the past 12 months?
Becton Dickinson And Company lowest stock price was $163.33 and its highest was $251.99 in the past 12 months.
What is Becton Dickinson And Company’s market cap?
Becton Dickinson And Company’s market cap is $48.91B.
When is Becton Dickinson And Company’s upcoming earnings report date?
Becton Dickinson And Company’s upcoming earnings report date is Aug 07, 2025 which is in 62 days.
How were Becton Dickinson And Company’s earnings last quarter?
Becton Dickinson And Company released its earnings results on May 01, 2025. The company reported $3.35 earnings per share for the quarter, beating the consensus estimate of $3.28 by $0.07.
Is Becton Dickinson And Company overvalued?
According to Wall Street analysts Becton Dickinson And Company’s price is currently Undervalued.
Does Becton Dickinson And Company pay dividends?
Becton Dickinson And Company pays a Quarterly dividend of $1.039 which represents an annual dividend yield of 2.33%. See more information on Becton Dickinson And Company dividends here
What is Becton Dickinson And Company’s EPS estimate?
Becton Dickinson And Company’s EPS estimate is 3.43.
How many shares outstanding does Becton Dickinson And Company have?
Becton Dickinson And Company has 286,607,420 shares outstanding.
What happened to Becton Dickinson And Company’s price movement after its last earnings report?
Becton Dickinson And Company reported an EPS of $3.35 in its last earnings report, beating expectations of $3.28. Following the earnings report the stock price went down -18.132%.
Which hedge fund is a major shareholder of Becton Dickinson And Company?
Currently, no hedge funds are holding shares in BDX
Becton Dickinson Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$200.73 (17.37% Upside)
$200.73 (17.37% Upside)
Blogger Sentiment
Bullish
BDX Sentiment 90%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 2.7M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $159.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.3%
Last 30 Days ▼ 3.8%
Last 30 Days ▼ 3.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.07%
12-Months-Change
Fundamentals
Return on Equity
5.97%
Trailing 12-Months
Asset Growth
0.57%
Trailing 12-Months
Company Description
Becton Dickinson And Company
Becton Dickinson (BDX) is a global medical technology company that is primarily involved in the development, manufacture, and sale of a broad range of medical supplies, devices, laboratory equipment, and diagnostic products. The company operates across several sectors, including Medical, Life Sciences, and Interventional, offering core products such as needles, syringes, infusion therapy systems, surgical instruments, and diagnostic systems.
BDX Company Deck
BDX Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call revealed a mixed performance for BD, with strong adjusted EPS growth and strategic investments being overshadowed by revenue challenges and external market pressures in Life Sciences, Diagnostics, and the China market. Tariff impacts further complicate the outlook.Read More>BDX Revenue Breakdown
57.80% U.S.
21.82% EMEA
14.40% Greater Asia
5.98% Other
BDX Stock 12 Month Forecast
Average Price Target
$200.73
▲(17.37%Upside)